Lacosamide Tablet, Film Coated
Product Images NDC 31722-813

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-fig1 (Lacosamide Fig1)

A bar graph showing seizure reduction (median % change from baseline) across three studies comparing placebo and Lacosamide at various doses (200 mg/day, 400 mg/day, 600 mg/day). Lacosamide groups show higher seizure reduction percentages than placebo, with statistical significance indicated in Studies 3 and 4. The x-axis displays treatment groups and doses, and the y-axis shows seizure reduction percentages from 0% to 45%.*

FDA Label Image

Lacosamide-fig2 (Lacosamide Fig2)

A line graph showing responder rate (equal to or greater improvement versus worsening) on the y-axis and percent of patients on the x-axis. The graph compares placebo and three dosages of Lacosamide (200 mg/day, 400 mg/day, 600 mg/day), tracking patient response rates with distinct lines for each group.*

FDA Label Image

Lacosamide-fig4 (Lacosamide Fig4)

Lacosamide 50 mg film coated tablets label from Camber Pharmaceuticals, Inc., containing 60 tablets. The label includes storage instructions, contact information, and a barcode. It specifies the medication is prescription only with dosing details referenced to the package insert.*

FDA Label Image

Lacosamide-fig5 (Lacosamide Fig5)

Label for Lacosamide Tablets, USP 100 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label includes dosage strength, quantity of 60 tablets, storage instructions, a barcode, and contact details for the manufacturer and distributor. The label specifies the product is Rx only and highlights a medication guide statement.*

FDA Label Image

Lacosamide-fig6 (Lacosamide Fig6)

Lacosamide Tablets, USP 150 mg film-coated oral tablets label by Camber Pharmaceuticals, Inc. The label shows 60 tablets per pack, with storage instructions between 20° to 25°C (68° to 77°F). It includes the NDC 31722-814-60, pharmacist dispensing instructions, contact information, and a barcode. The label also notes a blank area reserved for batch coding.*

FDA Label Image

Lacosamide-fig7 (Lacosamide Fig7)

Label for Lacosamide Tablets, USP 200 mg by Camber Pharmaceuticals, Inc. The label states 60 film-coated tablets for oral use, includes storage instructions (20° to 25°C), a barcode, manufacturer and distributor information, and a note to dispense the medication guide. The label also has a designated pink area for batch coding.*

FDA Label Image

Lacosamide-logo1 (Lacosamide Logo1)

FDA Label Image

Lacosamide-logo2 (Lacosamide Logo2)

FDA Label Image

Chemical Structure (Lacosamide Str)

Chemical structure of lacosamide, showing its molecular arrangement with functional groups including an amide, methoxy, and phenyl group, corresponding to the active ingredient lacosamide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.